XML 79 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Schedule of Nonvested Performance-based Units Activity [Table Text Block]
The number of PSUs outstanding under all of the Company’s equity plans are as follows (in thousands, except for grant date fair value amounts):
 
Year ended
December 30, 2017
 
Year ended
December 31, 2016
 
Year ended
January 2, 2016
 
Units
 
Weighted Average
Grant Date
Fair Value
 
Units
 
Weighted Average
Grant Date
Fair Value
 
Units
 
Weighted Average
Grant Date
Fair Value
PSUs outstanding, beginning of period

 
$

 

 
$

 

 
$

Granted
248

 
90.71

 

 

 

 

Canceled
(15
)
 
90.87

 

 

 

 
 
Expired

 

 

 

 

 

Vested

 

 

 

 

 

PSUs outstanding, end of period
233

 
$
90.70

 

 
$

 

 
$

 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
The number of RSUs issued and outstanding under all of the Company’s equity plans are as follows (in thousands, except for grant date fair value amounts):
 
Year ended
December 30, 2017
 
Year ended
December 31, 2016
 
Year ended
January 2, 2016
 
Units
 
Weighted Average
Grant Date
Fair Value
 
Units
 
Weighted Average
Grant Date
Fair Value
 
Units
 
Weighted Average
Grant Date
Fair Value
RSUs outstanding, beginning of period
2,706

 
$
95.40

 
2,703

 
$
41.45

 

 
$

Granted
33

 
86.42

 
6

 
43.09

 
2,703

 
41.45

Canceled
(25
)
 
85.79

 

 

 

 

Expired

 

 

 

 

 

Vested
(6
)
 
43.09

 
(3
)
 
41.45

 

 

RSUs outstanding, end of period
2,708

 
$
95.51

 
2,706

 
$
41.45

 
2,703

 
$
41.45

 
Number and Weighted Average Exercise Price of Options Issued and Outstanding under All Stock Option Plans
number and weighted-average exercise price of stock options issued and outstanding under all stock plans, is presented below (in thousands, except for exercise price):
 
Year ended
December 30,
2017
 
Year ended
December 31,
2016
 
Year ended
January 2,
2016
 
Shares
 
Average
Exercise
Price
 
Shares
 
Average
Exercise
Price
 
Shares
 
Average
Exercise
Price
Options outstanding, beginning of period
8,521

 
$
28.56

 
9,202

 
$
25.46

 
9,956

 
$
23.59

Granted
928

 
86.69

 
1,290

 
39.94

 
914

 
36.18

Canceled
(250
)
 
38.59

 
(172
)
 
29.13

 
(218
)
 
24.33

Expired

 

 

 

 

 

Exercised
(2,246
)
 
27.63

 
(1,799
)
 
20.76

 
(1,450
)
 
19.54

Options outstanding, end of period
6,953

 
$
36.26

 
8,521

 
$
28.56

 
9,202

 
$
25.46

Options exercisable, end of period
3,812

 
$
26.28

 
4,988

 
$
26.33

 
5,609

 
$
24.72

 
Number and Weighted Average Exercise Price of Outstanding and Exercisable Options  
The number and weighted-average exercise price of outstanding and exercisable stock options segregated by exercise price ranges (in thousands, except range of exercise prices and remaining contractual life) were as follows:
 
Year ended
December 30,
2017
 
Year ended
December 31,
2016
 
Options Outstanding
 
Options
Exercisable
 
Options Outstanding
 
Options
Exercisable
Range of Exercise Prices
Number of
Options
 
Average
Remaining
Contractual
Life
 
Number of
Options
 
Number of
Options
 
Average
Remaining
Contractual
Life
 
Number of
Options
$8.00 to $25.00
2,555

 
4.62
 
1,999

 
3,432

 
5.28
 
2,301

$25.01 to $40.00
3,224

 
5.80
 
1,712

 
4,664

 
5.65
 
2,526

$40.01 to $55.00
199

 
7.12
 
86

 
341

 
6.44
 
161

$55.01 to $70.00
94

 
8.80
 
15

 
84

 
9.76
 

$70.01 to $85.00
74

 
9.68
 

 

 
0
 

$85.01 to $105.00
807

 
9.57
 

 

 
0
 

     Total
6,953

 
5.92
 
3,812

 
8,521

 
5.57
 
4,988

Range of Assumptions Used and Resulting Weighted-Average Fair Value of Options Granted at Date of Grant
The range of assumptions used and the resulting weighted-average fair value of stock options granted at the date of grant were as follows:
 
Year ended
December 30,
2017
 
Year ended
December 31,
2016
 
Year ended
January 2,
2016
Risk-free interest rate
1.7% to 2.2%
 
1.0% to 2.1%
 
1.3% to 1.9%
Expected term
5.5 years to 5.6 years
 
5.5 years to 5.7 years
 
5.5 years to 5.7 years
Estimated volatility
29.7% to 32.1%
 
29.8% to 35.7%
 
32.0% to 37.4%
Expected dividends
0%
 
0%
 
0%
Weighted-average fair value of options granted
$27.81 per share
 
$13.64 per share
 
$12.20 per share
 
Total Share-Based Compensation Expense Included in Consolidated Statements of Comprehensive Income
The following table presents the total stock-based compensation expense that is included in each functional line item of the consolidated statements of operations (in thousands):
 
Year ended
December 30,
2017
 
Year ended
December 31,
2016
 
Year ended
January 2,
2016
Cost of goods sold
$
351

 
$
355

 
$
348

Selling, general and administrative
13,272

 
9,443

 
8,139

Research and development
3,564

 
2,705

 
2,338

Total
$
17,187

 
$
12,503

 
$
10,825